Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHED for Decompensated Liver Cirrhosis
NCT03957655Phase 1Unknown
- Sponsor
- Changhai Hospital
- Start
- Dec 2019
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of SHED in Liver cirrhosis (LC) (2 arms), sponsored by Changhai Hospital. Primary endpoint: Model for End-Stage Liver Disease-Na at 24 weeks. Status: unknown.
02
Drugs
SHED
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT03957655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03957655.